PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

When you say they're looking at all options to raise...

  1. 868 Posts.
    lightbulb Created with Sketch. 216
    When you say they're looking at all options to raise non-dilutive capital, but options are limited, it makes it seem that an MPS deal or a regional OA deal is unlikely even though it was indicated there would be some form of deal in the first 6 months of this year.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.